Get started
Portage Biotech Inc.Portage Biotech Inc.Portage Biotech Inc.

Portage Biotech Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

PRTG chart


Full chart

PRTG upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪6.04 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−65.69 USD
Net income (FY)
‪−75.34 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪438.10 K‬
Beta (1Y)
1.27

Employees


Employees (FY)
7
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−10.76 M‬ USD

About Portage Biotech Inc.


Sector
Health Technology
Industry
Biotechnology
Headquarters
Road Town
Website
portagebiotech.com
Founded
1973
FIGI
BBG000L8TTY6
Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PRTG news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PRTG is 5.19 USD — it has decreased by −3.71% in the past 24 hours. Watch Portage Biotech Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Portage Biotech Inc. stocks are traded under the ticker PRTG.
PRTG stock has fallen by −42.59% compared to the previous week, the month change is a 16.72% rise, over the last year Portage Biotech Inc. has showed a −80.04% decrease.
PRTG reached its all-time high on Dec 23, 1999 with the price of 16,375.00 USD, and its all-time low was 0.20 USD and was reached on Nov 20, 2018. View more price dynamics on PRTG chart.
See other stocks reaching their highest and lowest prices.
PRTG stock is 17.17% volatile and has beta coefficient of 1.27. Track Portage Biotech Inc. stock price on the chart and check out the list of the most volatile stocks — is Portage Biotech Inc. there?
Today Portage Biotech Inc. has the market capitalization of ‪3.59 M‬, it has decreased by −40.38% over the last week.
Yes, you can track Portage Biotech Inc. financials in yearly and quarterly reports right on TradingView.
Portage Biotech Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
PRTG net income for the last quarter is ‪−1.36 M‬ USD, while the quarter before that showed ‪−1.66 M‬ USD of net income which accounts for 17.87% change. Track more Portage Biotech Inc. financial stats to get the full picture.
No, PRTG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 7.00 employees. See our rating of the largest employees — is Portage Biotech Inc. on this list?
Like other stocks, PRTG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Portage Biotech Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Portage Biotech Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Portage Biotech Inc. stock shows the sell signal. See more of Portage Biotech Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.